Entire Cohort (n = 100) | Dead at day 28 (n = 51) | Alive at day 28 (n = 49) | p value | |
---|---|---|---|---|
Age, Years (mean, SD) | 48.9 (14.1) | 48.3 (15.2) | 49.5 (12.9) | 0.68 |
Male Sex (n, %) | 72 / 100 (72.0%) | 36 / 51 (70.6%) | 36 / 49 (73.5%) | 0.75 |
Weight, kg (mean, SD) | 81.1 (18.9) | 85.4 (18.7) | 77.1 (18.3) | 0.04 |
Pre-Existing Comorbidities, n (%) | ||||
MI | 4 / 99 (4.0%) | 3 / 50 (6.0%) | 1 / 49 (2.0%) | 0.62 |
Congestive Cardiac Failure | 9/ 99 (9.1%) | 3 / 50 (6.0%) | 6 / 49 (12.2%) | 0.47 |
PVD | 2 / 99 (2.0%) | 2 / 50 (4.0%) | 0 / 49 (0.0%) | 0.50 |
Connective Tissue Disease | 5 / 99 (5.1%) | 0 / 50 (0.0%) | 5 / 49 (10.2%) | 0.053 |
Diabetes Mellitus a | 14 / 99 (14.1%) | 11 / 50 (22.0%) | 3 / 49 (6.1%) | 0.023 |
Diagnosis, n (%) | ||||
AMI | 47 / 100 (47.0%) | 22 / 51 (43.1%) | 25 / 49 (51.0%) | 0.43 |
Myocarditis | 3 / 100 (3.0%) | 1 / 51 (2.0%) | 2 / 49 (4.1%) | 0.97 |
Primary Arrhythmia | 14 / 100 (14.0%) | 9 / 51 (17.6%) | 5 / 49 (10.2%) | 0.28 |
Acute Decompensated Heart Failure | 3 / 100 (4.0%) | 1 / 51 (2.0%) | 2 / 49 (4.1%) | 0.97 |
PE | 9 / 100 (9.0%) | 4 / 51 (7.8%) | 5 / 49 (10.2%) | 0.95 |
Toxic | 3 / 100 (3.0%) | 1 / 51 (2.0%) | 2 / 49 (4.1%) | 0.97 |
Cardiac Arrest Characteristics, n (%) | ||||
OHCA | 54 / 100 (54.0%) | 33 / 51 (64.7%) | 21 / 49 (42.9%) | 0.03 |
Witnessed | 81 / 99 (81.8%) | 37 / 50 (74.0%) | 44 / 49 (89.8%) | 0.042 |
Bystander CPR | 99 / 99 (100.0%) | 50 / 50 (100.0%) | 49 / 49 (100.0%) | 1.00 |
Shockable Initial Rhythm | 51 / 96 (53.1%) | 26 / 51 (52%) | 25 / 45 (55.6%) | 0.73 |
Low Flow Time, minutes (Median, IQR)b | 52.5 (39–76) | 60 (40–80) | 45 (37–73) | 0.65 |
Any ROSCc | 33 / 97 (34.0%) | 11 / 49 (22.4%) | 22/48 (45.8%) | 0.015 |
Biochemical parameters closest to ECMO cannulation | ||||
pH (mean, SD) | 7.01 (0.29) | 6.91 (0.28) | 7.11 (0.27) | 0.007 |
Bicarbonate, mmol/L (mean, SD) | 16.2 (6.2) | 15.1 (5.8) | 17.2 (6.5) | 0.19 |
Lactate, mmol/L (mean, SD) | 9.8 (5.6) | 10.7 (5.2) | 9.01 (5.8) | 0.22 |